개 백신 시장 - 규모, 점유율, 동향 분석 보고서 : 백신 유형별, 질환 유형별, 투여 경로별, 면역 기간별, 성분별, 지역별, 부문 예측(2025-2030년)

Dog Vaccine Market Growth & Trends:

The global dog vaccine market size is anticipated to reach USD 2.88 billion by 2030 and display a CAGR of 6.45% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth can be attributed to the increasing trend of pet humanization, pet ownership among millennials, and rising consciousness regarding preventive healthcare. According to Boehringer Ingelheim International GmbH, 35% of millennials and 32% of baby boomers own a pet. In addition, the rise in pet spending and insurance is also expected to add to the growth of this market. According to an article published by WorldAnimalFoundation.org in February 2023, dog owners spent approximately USD 570 more than cat owners.

Moreover, the increasing pet population, rising income levels in emerging markets of Asia-Pacific, such as China and India, and consequent changes in the lifestyle of people are expected to impact the growth of the dog vaccine industry significantly. For instance, according to an article published by the Economic Times in July 2023, the per capita income in India is expected to increase by 1.6 times to reach USD 4000 by 2030.

Dog Vaccine Market Report Highlights:

• Based on vaccine type, the modified/attenuated live vaccine segment accounted for the largest revenue share of 52.03% in 2024, as they help prevent disease and provide long-term immunity.
• Based on disease type, the canine rabies segment is expected to grow at the fastest CAGR of 7.3% over the forecast period due to the high prevalence of this disease and its zoonotic potential.
• Based on route of administration, the oral vaccine segment is expected to grow at the fastest CAGR from 2025 to 2030.
• Based on duration of immunity, the 1-year segment dominated the market with a share of 51.2% in 2024 owing to their convenience.
• Based on component, the combined vaccines segment accounted for the largest market share of 65%. It is expected to grow at the fastest CAGR over the forecast period due to its ability to protect against more than one disease.
• North America dominated with a share of 38% in 2024, owing to the presence of major players and increasing awareness regarding preventive healthcare for pets. On the other hand, the Asia Pacific dogs vaccine market is expected to grow at the fastest CAGR over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Duration of Immunity
  • 1.2.2. Vaccine Type
  • 1.2.3. Disease type
  • 1.2.4. Route of Administration
  • 1.2.5. Distribution Channel
  • 1.2.6. Regional Scope
  • 1.2.7. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Dogs Vaccines Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising pet ownership and pet humanization
    • 3.2.1.2. Increasing concerns over zoonotic diseases
    • 3.2.1.3. Technological advancements
    • 3.2.1.4. Initiatives by market participants
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Lack of adoption of immunization in endemic cuntries
• 3.3. Dogs Vaccines Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape
    • 3.3.2.7. Estimated Dog Population by key Species, key Country, 2018-2024
• 3.4. Regulatory Framework
• 3.5. Pricing Analysis
• 3.6. COVID-19 impact Analysis

Chapter 4. Dogs Vaccines Market: Durastion of Immunity Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Dogs Vaccines Market: Duration of Immunity Movement Analysis
• 4.3. Dogs Vaccines Market by Duration of Immunity Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. 1 year
  • 4.5.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 4.6. 3 years
  • 4.6.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 4.7. Others
  • 4.7.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 5. Dogs Vaccines Market: Vaccine Type Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Dogs Vaccines Market: Vaccine Type Movement Analysis
• 5.3. Dogs Vaccines Market by Vaccine Type Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Modified/ Attenuated Live
  • 5.5.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 5.6. Inactivated (Killed)
  • 5.6.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 5.7. Other Vaccines
  • 5.7.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6. Dogs Vaccines Market: Disease Type Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Dogs Vaccines Market: Disease type Movement Analysis
• 6.3. Dogs Vaccines Market by Disease type Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Canine Distemper
  • 6.5.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 6.6. Canine Infectious Respiratory Disease Complex (CIRDC)
  • 6.6.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 6.7. Canine Parvovirosis/ Parvovirus Disease
  • 6.7.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 6.8. Canine Leptospirosis
  • 6.8.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 6.9. Canine Lyme Disease
  • 6.9.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 6.10. Infectious Canine Hepatitis
  • 6.10.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 6.11. Canine Rabies
  • 6.11.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 6.12. Other Diseases
  • 6.12.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7. Dogs Vaccines Market: Route of Administration Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Dogs Vaccines Market: Route of Administration Movement Analysis
• 7.3. Dogs Vaccines Market by Route of Administration Outlook (USD Million)
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. Injectable
  • 7.5.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 7.6. Intranasal
  • 7.6.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 7.7. Oral
  • 7.7.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8. Dogs Vaccines Market: Component Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Dogs Vaccines Market: Component Movement Analysis
• 8.3. Dogs Vaccines Market by Component Outlook (USD Million)
• 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 8.5. Combined Vaccines
  • 8.5.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 8.6. Mono Vaccines
  • 8.6.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 9. Dogs Vaccines Market: Distribution Channel Estimates & Trend Analysis

• 9.1. Segment Dashboard
• 9.2. Dogs Vaccines Market: Distribution Channel Movement Analysis
• 9.3. Dogs Vaccines Market by Distribution Channel Outlook (USD Million)
• 9.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 9.5. Retail
  • 9.5.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 9.6. E-Commerce
  • 9.6.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 9.7. Hospital/Clinic Pharmacies
  • 9.7.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 10. Dogs Vaccines Market: Regional Estimates & Trend Analysis

• 10.1. Regional Dashboard
• 10.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 10.3. North America
  • 10.3.1. U.S.
    • 10.3.1.1. Key country dynamics
    • 10.3.1.2. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.3.2. Canada
    • 10.3.2.1. Key country dynamics
    • 10.3.2.2. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.3.3. Mexico
    • 10.3.3.1. Key country dynamics
    • 10.3.3.2. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 10.4. Europe
  • 10.4.1. UK
    • 10.4.1.1. Key country dynamics
    • 10.4.1.2. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.4.2. Germany
    • 10.4.2.1. Key country dynamics
    • 10.4.2.2. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.4.3. France
    • 10.4.3.1. Key country dynamics
    • 10.4.3.2. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.4.4. Italy
    • 10.4.4.1. Key country dynamics
    • 10.4.4.2. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.4.5. Spain
    • 10.4.5.1. Key country dynamics
    • 10.4.5.2. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.4.6. Sweden
    • 10.4.6.1. Key country dynamics
    • 10.4.6.2. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.4.7. Denmark
    • 10.4.7.1. Key country dynamics
    • 10.4.7.2. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.4.8. Norway
    • 10.4.8.1. Key country dynamics
    • 10.4.8.2. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.4.9. Rest of Europe
    • 10.4.9.1. Key country dynamics
    • 10.4.9.2. Rest of Europe market estimates and forecasts 2018 to 2030 (USD Million)
• 10.5. Asia Pacific
  • 10.5.1. Japan
    • 10.5.1.1. Key country dynamics
    • 10.5.1.2. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.5.2. China
    • 10.5.2.1. Key country dynamics
    • 10.5.2.2. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.5.3. India
    • 10.5.3.1. Key country dynamics
    • 10.5.3.2. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.5.4. Australia
    • 10.5.4.1. Key country dynamics
    • 10.5.4.2. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.5.5. South Korea
    • 10.5.5.1. Key country dynamics
    • 10.5.5.2. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.5.6. Thailand
    • 10.5.6.1. Key country dynamics
    • 10.5.6.2. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.5.7. Rest of Asia-Pacific
    • 10.5.7.1. Key country dynamics
    • 10.5.7.2. Rest of Asia-Pacific market estimates and forecasts 2018 to 2030 (USD Million)
• 10.6. Latin America
  • 10.6.1. Brazil
    • 10.6.1.1. Key country dynamics
    • 10.6.1.2. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.6.2. Argentina
    • 10.6.2.1. Key country dynamics
    • 10.6.2.2. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.6.3. Rest of LA
    • 10.6.3.1. Key country dynamics
    • 10.6.3.2. Rest of LA market estimates and forecasts 2018 to 2030 (USD Million)
• 10.7. MEA
  • 10.7.1. South Africa
    • 10.7.1.1. Key country dynamics
    • 10.7.1.2. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.7.2. Saudi Arabia
    • 10.7.2.1. Key country dynamics
    • 10.7.2.2. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.7.3. UAE
    • 10.7.3.1. Key country dynamics
    • 10.7.3.2. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.7.4. Kuwait
    • 10.7.4.1. Key country dynamics
    • 10.7.4.2. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.7.5. Rest of MEA
    • 10.7.5.1. Key country dynamics
    • 10.7.5.2. Rest of MEA market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 11. Competitive Landscape

• 11.1. Company Categorization
• 11.2. Recent Developments & Impact Analysis by Key Market Participants
• 11.3. Company Market Share Analysis, 2024
• 11.4. Company overview
  • 11.4.1. Boehringer Ingelheim International GmbH
    • 11.4.1.1. Company Overview
    • 11.4.1.2. Financial performance
    • 11.4.1.3. Product benchmarking
    • 11.4.1.4. Strategic initiatives
  • 11.4.2. Zoetis Services LLC
    • 11.4.2.1. Company Overview
    • 11.4.2.2. Financial performance
    • 11.4.2.3. Product benchmarking
    • 11.4.2.4. Strategic initiatives
  • 11.4.3. Hester Biosciences Limited
    • 11.4.3.1. Company Overview
    • 11.4.3.2. Financial performance
    • 11.4.3.3. Product benchmarking
    • 11.4.3.4. Strategic initiatives
  • 11.4.4. Merck & Co., Inc.
    • 11.4.4.1. Company Overview
    • 11.4.4.2. Financial performance
    • 11.4.4.3. Product benchmarking
    • 11.4.4.4. Strategic initiatives
  • 11.4.5. Virbac
    • 11.4.5.1. Company Overview
    • 11.4.5.2. Financial performance
    • 11.4.5.3. Product benchmarking
    • 11.4.5.4. Strategic initiatives
  • 11.4.6. Bioveta a.s
    • 11.4.6.1. Company Overview
    • 11.4.6.2. Financial performance
    • 11.4.6.3. Product benchmarking
    • 11.4.6.4. Strategic initiatives
  • 11.4.7. Elanco
    • 11.4.7.1. Company Overview
    • 11.4.7.2. Financial performance
    • 11.4.7.3. Product benchmarking
    • 11.4.7.4. Strategic initiatives
  • 11.4.8. Brilliant Bio Pharma
    • 11.4.8.1. Company Overview
    • 11.4.8.2. Financial performance
    • 11.4.8.3. Product benchmarking
    • 11.4.8.4. Strategic initiatives
  • 11.4.9. Heska Corporation
    • 11.4.9.1. Company Overview
    • 11.4.9.2. Financial performance
    • 11.4.9.3. Product benchmarking
    • 11.4.9.4. Strategic initiatives
  • 11.4.10. Zendal Group
    • 11.4.10.1. Company Overview
    • 11.4.10.2. Financial performance
    • 11.4.10.3. Product benchmarking
    • 11.4.10.4. Strategic initiatives